Low-dose oral bexarotene in combination with low-dose interferon alfa in the treatment of cutaneous T-cell lymphoma: clinical synergism and possible immunologic mechanisms-Reference-Cited by-同舟云学术

Low-dose oral bexarotene in combination with low-dose interferon alfa in the treatment of cutaneous T-cell lymphoma: clinical synergism and possible immunologic mechanisms

Published:2004-03 Issue:3 Volume:50 Page:375-379
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

McGinnis Karen S,Junkins-Hopkins Jacqueline M,Crawford Glen,Shapiro Michael,Rook Alain H,Vittorio Carmela C

Publisher

Elsevier BV

Subject

Dermatology

Reference43 articles.

1. Treatment of mycosis fungoides with recombinant interferon-alpha-2a alone and in combination with etretinate;Thestrup-Pedersen;Br J Dermatol,1988

2. Successful treatment of mycosis fungoides with the combination of etretinate and human recombinant interferon alfa-2a;Braathen;J Dermatol Treat,1989

3. Knobler RM, Trautinger F, Radaszkiewicz T, Kokoschka EM, Micksche M. Treatment of cutaneous T-cell lymphoma with a combination of low-dose interferon alfa-2b and retinoids. J Am Acad Dermatol 1991;24:247-52

4. Dreno B, Claudy A, Meynadier J, Verret JL, Souteyrand P, Ortonne JP, et al. The treatment of 45 patients with cutaneous T-cell lymphoma with low doses of interferon-alfa 2a and etretinate. Br J Dermatol 1991;125:456-9

5. Intramuscular low dose alpha-2b interferon and etretinate for treatment of mycosis fungoides;Altomare;Int J Dermatol,1993

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mycosis Fungoides and Sézary Syndrome;Holland‐Frei Cancer Medicine;2022-10-21

2. Effectiveness of combined bexarotene and excimer laser treatment for folliculotropic mycosis fungoides;European Journal of Dermatology;2021-08

3. Topical and Systemic Formulation Options for Cutaneous T Cell Lymphomas;Pharmaceutics;2021-02-02

4. Efficacy, quality of life, and safety of methotrexate versus interferon in head-to-head treatment in advanced stages of mycosis fungoides and Sezary syndrome. Prospective trial (NCT02323659);Advances in Dermatology and Allergology;2021

5. Real-world data on the effectiveness and safety of interferon-alpha-2a intralesional injection for the treatment of focally recalcitrant mycosis fungoides;Annals of Translational Medicine;2020-08